Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. (11th May 2005)

• Record Type: Journal Article
• Authors: Ramage, J K; Davies, A H G; Ardill, J; Bax, N; Caplin, M; Grossman, A; Hawkins, R; McNicol, A M; Reed, N; Sutton, R; Thakker, R; Aylwin, S; Breen, D; Britton, K; Buchanan, K; Corrie, P; Gillams, A; Lewington, V; McCance, D; Meeran, K; Watkinson, A
• Other Names: group-author.
• Is Part Of: Gut. Volume 54(2005)Supplement 4
• Page Start: iv1
• Page End: iv16
• Publication Date: 2005-05-11
• Subjects: NET, neuroendocrine tumour -- MEN, multiple endocrine neoplasia -- NF1, neurofibromatosis type 1 -- CgA, chromogranin A -- PTH, parathyroid hormone -- CEA, carcinoembryonic antigen -- β-HCG, β-human chorionic gonadotrophin -- 5-HIAA, 5-hydroxy indole acetic acid -- ACTH, adrenocorticotrophic hormone -- CT, computed tomography -- MRI, magnetic resonance imaging -- SSRS, somatostatin receptor scintigraphy -- SSTR, somatostatin receptors -- EUS, endoscopic ultrasound -- TFTs, thyroid function tests -- DSA, digital subtraction angiography -- SMS, somatostatin; guidelines -- gastroenteropancreatic neuroendocrine tumours -- carcinoid tumours; Gastroenterology -- Periodicals; 616.33
• DOI: 10.1136/gut.2004.053314
• Languages: English
• ISSNs: 0017-5749